Literature DB >> 21804353

Both, toxin A and toxin B, are important in Clostridium difficile infection.

Sarah A Kuehne1, Stephen T Cartman, Nigel P Minton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21804353      PMCID： PMC3260544          DOI： 10.4161/gmic.2.4.16109

Source DB:  PubMed          Journal:  Gut Microbes        ISSN： 1949-0976


× No keyword cloud information.
  33 in total

1.  Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain.

Authors:  E J Kuijper; J de Weerdt; H Kato; N Kato; A P van Dam; E R van der Vorm; J Weel; C van Rheenen; J Dankert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-08       Impact factor: 3.267

2.  Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker.

Authors:  Jin Zhong; Michael Karberg; Alan M Lambowitz
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

3.  Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor.

Authors:  N Mani; B Dupuy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

4.  Clostridium beijerinckii and Clostridium difficile detoxify methylglyoxal by a novel mechanism involving glycerol dehydrogenase.

Authors:  H Liyanage; S Kashket; M Young; E R Kashket
Journal:  Appl Environ Microbiol       Date:  2001-05       Impact factor: 4.792

Review 5.  Clostridium difficile: progress and challenges.

Authors:  John G Bartlett
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

6.  A Clostridium difficile gene encoding flagellin.

Authors:  A Tasteyre; M C Barc; T Karjalainen; P Dodson; S Hyde; P Bourlioux; P Borriello
Journal:  Microbiology       Date:  2000-04       Impact factor: 2.777

Review 7.  Clostridium difficile-associated diarrhea in adults.

Authors:  Susan M Poutanen; Andrew E Simor
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

8.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

Authors:  D M Lyerly; L A Barroso; T D Wilkins; C Depitre; G Corthier
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.

Authors:  C Depitre; M Delmee; V Avesani; R L'Haridon; A Roels; M Popoff; G Corthier
Journal:  J Med Microbiol       Date:  1993-06       Impact factor: 2.472

10.  Effects of Clostridium difficile toxins given intragastrically to animals.

Authors:  D M Lyerly; K E Saum; D K MacDonald; T D Wilkins
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441
View more
  33 in total

1.  Clostridium difficile infection in older adults.

Authors:  Robin Lp Jump
Journal:  Aging health       Date:  2013-08-01

2.  CodY-Dependent Regulation of Sporulation in Clostridium difficile.

Authors:  Kathryn L Nawrocki; Adrianne N Edwards; Nadine Daou; Laurent Bouillaut; Shonna M McBride
Journal:  J Bacteriol       Date:  2016-07-13       Impact factor: 3.490

Review 3.  Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.

Authors:  Gayatri Vedantam; Andrew Clark; Michele Chu; Rebecca McQuade; Michael Mallozzi; V K Viswanathan
Journal:  Gut Microbes       Date:  2012-03-01

4.  Subinhibitory concentrations of LFF571 reduce toxin production by Clostridium difficile.

Authors:  Meena Sachdeva; Jennifer A Leeds
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

Review 5.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

6.  The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates.

Authors:  Paul E Carlson; Seth T Walk; Alexandra E T Bourgis; Melissa W Liu; Fatos Kopliku; Eugene Lo; Vincent B Young; David M Aronoff; Philip C Hanna
Journal:  Anaerobe       Date:  2013-04-20       Impact factor: 3.331

7.  Comparison of polymerase chain reaction ribotyping, toxinotyping and nutritional aspects of toxin production of Clostridium difficile strains.

Authors:  Shanshan Zhu; Liming Zhang; Chunling Zhang; Xianjun Chen; Qi Chen; Zhaoyun Li
Journal:  Biomed Rep       Date:  2014-04-25

Review 8.  A clinical and epidemiological review of non-toxigenic Clostridium difficile.

Authors:  Mukil Natarajan; Seth T Walk; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2013-05-29       Impact factor: 3.331

9.  The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.

Authors:  Robert W McKee; Mihnea R Mangalea; Erin B Purcell; Erin K Borchardt; Rita Tamayo
Journal:  J Bacteriol       Date:  2013-09-13       Impact factor: 3.490

10.  Clostridium difficile extracytoplasmic function σ factor σV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection.

Authors:  Theresa D Ho; Kyle B Williams; Yan Chen; Richard F Helm; David L Popham; Craig D Ellermeier
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.